Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
melanoma
|
515 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 0.979 | 477 | 2002 | 2020 | |||||
Neoplasms
|
1644 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 0.947 | 475 | 2003 | 2020 | |||||
Papillary thyroid carcinoma
|
204 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 0.959 | 387 | 2003 | 2019 | |||||
Colorectal Carcinoma
|
1962 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.900 | 0.975 | 160 | 2004 | 2020 | |||||
Malignant Neoplasms
|
1641 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.990 | 98 | 2002 | 2020 | |||||
Thyroid carcinoma
|
145 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.980 | 98 | 2004 | 2019 | |||||
Metastatic melanoma
|
42 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 91 | 2004 | 2020 | |||||
Neoplasm Metastasis
|
327 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.876 | 89 | 2003 | 2019 | |||||
Thyroid Neoplasm
|
135 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.988 | 83 | 2003 | 2020 | |||||
Malignant neoplasm of thyroid
|
103 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.986 | 74 | 2004 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.986 | 69 | 2002 | 2020 | |||||
Secondary malignant neoplasm of lymph node
|
188 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.800 | 60 | 2004 | 2019 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.980 | 51 | 2005 | 2020 | |||||
Hairy Cell Leukemia
|
4 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.979 | 48 | 2011 | 2019 | |||||
Secondary Neoplasm
|
85 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.909 | 44 | 2003 | 2019 | |||||
Carcinogenesis
|
355 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.907 | 43 | 2003 | 2019 | |||||
Tumor Cell Invasion
|
169 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.927 | 41 | 2007 | 2018 | |||||
Thyroid Nodule
|
17 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.950 | 40 | 2006 | 2020 | |||||
Malignant tumor of colon
|
688 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.943 | 35 | 2004 | 2019 | |||||
Anaplastic thyroid carcinoma
|
16 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 34 | 2006 | 2019 | |||||
Colorectal Neoplasms
|
609 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.790 | 0.970 | 33 | 2002 | 2019 | |||||
Histiocytosis, Langerhans-Cell
|
12 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.970 | 33 | 2012 | 2019 | |||||
Colon Carcinoma
|
275 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.938 | 32 | 2004 | 2019 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 1.000 | 30 | 2002 | 2019 | |||||
Secondary malignant neoplasm of colon and/or rectum
|
68 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 28 | 2009 | 2019 |